1) Miyawaki S, et al.: Randomized study of individualized induction therapy with or without etoposide in adult acute myeloid leukemia (except for M3) (JALSG-AML92 study) and analysis of prognostic factors. Blood 90(Suppl.): 503a, 1997.
2) Davis CL, et al.: The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen-year period Br J Haematol 83: 404∼411, 1993.